Compare EBMT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EBMT | QSI |
|---|---|---|
| Founded | 1922 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 165.6M |
| IPO Year | 2009 | 2020 |
| Metric | EBMT | QSI |
|---|---|---|
| Price | $21.26 | $1.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $24.00 | $2.30 |
| AVG Volume (30 Days) | 21.0K | ★ 9.3M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 53.23 | 28.17 |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | $5.89 | N/A |
| Revenue Next Year | $3.84 | $406.32 |
| P/E Ratio | $21.79 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.80 | $0.69 |
| 52 Week High | $24.66 | $2.42 |
| Indicator | EBMT | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 60.23 |
| Support Level | $20.14 | $0.81 |
| Resistance Level | $22.49 | $1.66 |
| Average True Range (ATR) | 0.81 | 0.17 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 69.36 | 59.23 |
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.